NRAS and melanoma: Elevated BRAF-BRAF and BRAF-CRAF dimers were consistently observed in MEFs and primary melanocytes expressing NRAS mutants with strong melanoma-driving potential (Figs. 6b–g; Supplementary Figs. 10b–d, 11a–f; Supplementary Table 4c–e).